The Effects of Naloxone and Morphine on Postprandial Gastrointestinal Hormone Secretion

M. C. Champion, S. N. Sullivan, S. R. Bloom, T. E. Adrian, N. D. Christofides

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)


Postprandial gastrointestinal hormone secretion was not affected by the intravenous administration of naloxone. However, after the administration of morphine, multiple effects were observed. Postprandial pancreatic polypeptide, motilin, and enteroglucagon secretion were abolished and there was a reduction in the secretion of insulin, gastric inhibitory polypeptide, and neurotensin. There was prolonged secretion of gastrin. Levels of vasoactive intestinal polypeptide, somatostatin, and pancreatic glucagon were not affected. Many of these changes can be accounted for by the ability of morphine to delay gastric emptying. The prolonged secretion of gastrin could result from a combination of impaired gastric emptying and reduced postprandial gastric acid secretion. Inhibition of vagal acetylcholine release is the most likely explanation for the abolition of pancreatic polypeptide secretion. With the exception of the effects on motilin, pancreatic polypeptide, and enteroglucagon secretion this study provides no evidence that opiate substances directly affect the secretion of gastrointestinal hormones.

Original languageEnglish
Pages (from-to)617-620
Number of pages4
JournalThe American Journal of Gastroenterology
Issue number9
Publication statusPublished - Sept 1982
Externally publishedYes

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology


Dive into the research topics of 'The Effects of Naloxone and Morphine on Postprandial Gastrointestinal Hormone Secretion'. Together they form a unique fingerprint.

Cite this